title: Human myoblast transplantation: preliminary results of 4 cases.
abstract: Myoblasts from immunocompatible donors have been transplanted into the muscles (tibialis anterior, biceps brachii, and/or extensor carpi radialis longus) of 4 Duchenne patients in the advanced stages of the disease. Although no immunosuppressive treatment was used, none of the patients showed any clinical signs of rejection such as fever, redness, and inflammation. One patient transiently produced antibodies against the donor myoblasts as determined by cytofluorometric analysis. This patient and 2 others were shown to form antibodies against their donor's myotubes. Muscle biopsies of the injected tibialis anterior of 4 patients revealed that 80%, 75%, 25%, and 0% of the muscle fibers, respectively, showed some degree of dystrophin immunostaining. The contralateral noninjected muscles of the latter 3 patients did not contain any dystrophin positive fibers, while that of the first patient showed dystrophin expression in 16% of the fibers examined. Myoblasts were also injected into the extensor carpi radialis longus or the biceps brachii of these patients. A few months subsequent to injection, one patient was shown to have a 143% increase of strength during static wrist extension. This result must be interpreted with caution because a double-blind strength-measuring protocol was not used. Furthermore, we have noted that this change slowly decayed over time. The strength of 2 other patients was increased less remarkably (41% and 51%), while the strength of the fourth patient was unchanged.
authors.affiliation: Laboratoire de Neurobiologie, Hôpital de l'Enfant-Jésus, Québec, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Huard
authors.forename: J P
authors.initials: JP
authors.lastname: Bouchard
authors.forename: R
authors.initials: R
authors.lastname: Roy
authors.forename: F
authors.initials: F
authors.lastname: Malouin
authors.forename: G
authors.initials: G
authors.lastname: Dansereau
authors.forename: C
authors.initials: C
authors.lastname: Labrecque
authors.forename: N
authors.initials: N
authors.lastname: Albert
authors.forename: C L
authors.initials: CL
authors.lastname: Richards
authors.forename: B
authors.initials: B
authors.lastname: Lemieux
authors.forename: J P
authors.initials: JP
authors.lastname: Tremblay
mesh_terms: D000293:Adolescent; D002999:Clone Cells; D016189:Dystrophin / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005455:Fluorescent Antibody Technique; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D008297:Male; D009119:Muscle Contraction / Q000502:physiology; D009132:Muscles / Q000378:metabolism / Q000637:transplantation*; D009136:Muscular Dystrophies / Q000235:genetics / Q000601:surgery*
chemical_list: D016189:Dystrophin